See also this year's filing and all EDGAR filings for this company.
PDF Report 0001693011_2022_Inozyme_Pharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001693011')"} |
Graph
Absolute values for 0001693011, Inozyme Pharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 115,342,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,383,000 |
| 3 | remainder_Assets | 5,816,000 |
| 4 | LiabilitiesCurrent | 11,633,000 |
| 5 | LiabilitiesNoncurrent | 2,640,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,926,000 |
| 9 | ResearchAndDevelopmentExpense | 37,720,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 22,000 |
| 13 | remainder_ComprehensiveNetIncome | 16,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 123,541,000 |
| 1 | Liabilities | 14,273,000 |
| 2 | Expenses | 56,646,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 109,268,000 |
| 5 | NetIncome | -56,624,000 |
| 6 | ComprehensiveNetIncome | -56,616,000 |
| 7 | BaseVar | 97,249,000 |
| 8 | EconomicCapitalRatio | 1.91 |
Edgar->Model Mapping
Feature Distribution
Change over Time
